Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Non-Current Debt (2017 - 2023)

Marimed has reported Non-Current Debt over the past 7 years, most recently at $18.9 million for Q3 2023.

  • Quarterly Non-Current Debt changed N/A to $18.9 million in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $18.9 million through Sep 2023, changed N/A year-over-year, with the annual reading at $17.3 million for FY2021, 61.6% up from the prior year.
  • Non-Current Debt was $18.9 million for Q3 2023 at Marimed, down from $20.5 million in the prior quarter.
  • Over five years, Non-Current Debt peaked at $20.8 million in Q1 2023 and troughed at $46000.0 in Q1 2022.
  • The 5-year median for Non-Current Debt is $10.7 million (2020), against an average of $9.5 million.
  • Year-over-year, Non-Current Debt plummeted 98.58% in 2022 and then soared 45123.91% in 2023.
  • A 5-year view of Non-Current Debt shows it stood at $300000.0 in 2019, then surged by 3460.74% to $10.7 million in 2020, then skyrocketed by 61.6% to $17.3 million in 2021, then crashed by 99.73% to $46000.0 in 2022, then surged by 40976.09% to $18.9 million in 2023.
  • Per Business Quant, the three most recent readings for MRMD's Non-Current Debt are $18.9 million (Q3 2023), $20.5 million (Q2 2023), and $20.8 million (Q1 2023).